VISFO
Knowledge base
Trial site analysis
Adopt a data-driven approach to clinical trial site selection. Pinpoint ideal locations with the right patients, experienced investigators and strong infrastructure.
Definition and criteria
A well-recognized, highly respected and trusted expert with significant influence in their field. KOLs are often thought leaders and educators, whose perceptions are likely to impact the opinions and decisions of others in their professional network. To be considered a KOL, an individual may fulfill some or even all of the following criteria:
Criteria 1
Criteria 2
Criteria 3
Criteria 4
Criteria 5
Criteria 6
Power your decision-making
with bespoke and intuitive intelligence boards
Visualize
VISFO combines cutting-edge technology and deep subject matter expertise to de-silo data and enable confident decision-making. With all outputs housed in our fully interactive, AI-enhanced knowledge base. Teams can drill down from high-level strategy to granular evidence, surfacing the right information in seconds.
Identify
- Sites supporting experienced investigators familiar with the therapy area
- Sites conveniently located for your target patient population with a strong track record of efficient recruitment and retention for similar trials
- Popular, frequently used sites, based on metrics such as number of subjects per site and subject enrollment per site per month
Analyze
- Site capabilities and historical data on site performance to support optimal resource allocation and assess feasibility of completing investigations within the planned timeframe
- The geographic distribution of trial sites to achieve the desired patient enrollment diversity
- Site rankings according to a combined score of:
- enrollment efficiency (%)
- enrollment period (months)
- number of subjects per site per month (where sites with high enrollment efficiency, low enrollment period, and high subject count per site per month are ranked highly)
For a comprehensive view of both the trial site and investigator landscape, explore our complementary Key Clinical Investigator (KCI) mapping service. This service provides in-depth profiles to help identify and engage with the most influential investigators in your field.
Global systemic lupus erythematosus (SLE) trial site activity
Use cases
How can this help your team...
Medical Affairs
Identify top investigators to engage with for advisory boards, speaker programs, and clinical collaborations
Leverage the expertise of clinical investigators with strong publication records to support in the development of a robust publication plan
Stay informed about the latest clinical developments and adjust your medical strategies accordingly
Market Access
Gain a clear understanding of the clinical trial landscape to assess market potential and inform your market entry strategies
Engage with KCIs to gain advocacy for your product and insights to support your market access efforts
Identify sites with the capacity to run patient access programs, ensuring that patients in need can access the treatment early
Clinical Development
Select the most suitable trial sites for a new clinical study
Map investigators and trial sites to areas with high concentrations of eligible patients to optimize patient recruitment and retention strategies
Understand competitor activities in the clinical trial landscape to help avoid conflicts or identify potential collaboration opportunities
See it in action with an interactive demo
See how VISFO’s precision intelligence and collaborative approach ensures you have the right insights, at the right time, to make the best possible strategic decisions.
